Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotama ...
Daiichi Sankyo Co Ltd on Wednesday said that strong sales of its flagship medicines drove revenue growth in its lates ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved t ...
escription of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria) (Alliance News ...
AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US. The Cambri ...
A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a ...
AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketin ...
AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc. The Cambridge-based pharmaceutical ...
AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso. The Cambr ...
Daiichi Sankyo Co Ltd on Wednesday said it was raising annual guidance after seeing solid growth in the first nine mo ...
AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration i ...
Daiichi Sankyo Co Ltd on Tuesday said revenue in its first half year was up by 20% and increased its second quarterly ...
AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive result ...
Shares in Japan's Daiichi Sankyo Co Ltd soared on Friday after the pharma group announced a major cancer drug deal w ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.